KDR and glioblastoma: Having observed the test compounds to effectively inhibit blood vessel density at 1 and 10 μM, as well as reduced VEGF-A and VEGFR-2 gene transcript expression in CAM, the effect was further evaluated in CAM U87 xenograft models for GBM-induced angiogenesis.